3-Methylamphetamine (3-MA; PAL-314) is a stimulant drug from the amphetamine family. It is self-administered by mice to a similar extent to 4-fluoroamphetamine and has comparable properties as a monoamine releaser, although with a more balanced release of all three monoamines, as opposed to the more dopamine/noradrenaline selective fluoro analogues.
^Wee, S; Anderson, KG; Baumann, MH; Rothman, RB; Blough, BE; Woolverton, WL (2005). "Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs". The Journal of Pharmacology and Experimental Therapeutics313 (2): 848–54. doi:10.1124/jpet.104.080101. PMID15677348.
^Negus, SS; Mello, NK; Blough, BE; Baumann, MH; Rothman, RB (2007). "Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys". The Journal of Pharmacology and Experimental Therapeutics320 (2): 627–36. doi:10.1124/jpet.106.107383. PMID17071819.
This page is based on the copyrighted Wikipedia article ( 3-Methylamphetamine ); it is used under the
GNU Free Documentation License. You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.